National Lifestyle

NEW YORK (AP) — Jeff Shell, the chief executive of NBCUniversal and one of the media industry's renowned executives, is departing the company after an investigation into inappropriate conduct, parent company Comcast announced Sunday.

KNOXVILLE, Tenn. (AP) — In a concert Friday night in Knoxville, Tennessee, Lizzo filled the stage with drag queens in a glittery protest against the state's legislation designed to restrict drag performances in public.

NEW YORK (AP) — “The Super Mario Bros. Movie” continued to rack up coins at the box office, leading ticket sales for the third straight weekend, as the animation hit neared $1 billion after just 18 days in theaters.

METEN-MEER-ZORG, Guyana (AP) — The judges leaned in, hands clasped behind their backs. Everyone grew quiet as they stared at the two tiny black birds flitting before them, wondering which one would break the silence. “One.

NEW YORK (AP) — The American front door is a place where the welcome mat offers friendly greetings, where affable neighbors knock or ring, where boxes brimming with possibility are delivered.

NEW YORK (AP) — The marketing executive who oversaw a partnership between Bud Light and a transgender influencer is taking a leave of absence after it snowballed into cries for boycotts from some angry customers, according to media reports.

NEW YORK (AP) — TV personalities Gayle King and Charles Barkley will headline a new prime-time weekly CNN show, “King Charles,” debuting in the fall, the network announced Saturday as it tries to engineer a turnaround amid tumbling ratings .

LOS ANGELES (AP) — Actor Shannen Doherty of hit shows “Charmed” and “Beverly Hills, 90210” has filed for divorce from her husband, Kurt Iswarienko, after 11 years of marriage, her representative says.

NEW YORK (AP) — Days after Fox News agreed to pay nearly $800 million to settle a lawsuit over its airing of 2020 election lies, you'd be hard-pressed to notice anything had changed there.

Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV. Nirsevimab, also known by its brand name Beyfortus, was authorized on April 19.